Jacob Liawiaidiewi is a dynamic pharmaceutical industry leader with more than 25 years of experience in sales, marketing, and corporate administration. Holding a Bachelor’s degree in Business Administration from the University of California, Los Angeles, and an MBA from the Wharton School, he began his career at a major generic drug manufacturer, rising through the ranks to direct national sales teams and launch blockbuster products. His expertise in regulatory compliance, market penetration, and team leadership propelled him to executive roles at several mid-sized pharma firms, where he consistently drove double-digit revenue growth amid competitive landscapes. At Amphastar Pharmaceuticals Inc., Jacob serves as Executive Vice President of Sales and Marketing, Executive Vice President of Corporate Administration Center, and President of Amphastar France Pharmaceuticals, S.A.S. In these capacities, he orchestrates global sales strategies, optimizes marketing campaigns for injectable and specialty generics, and oversees administrative functions including HR, finance, and legal operations across the Corporate Administration Center. As President of the French subsidiary, he has expanded Amphastar’s European footprint, securing key partnerships and achieving a 40% year-over-year sales increase since its inception. Jacob’s notable achievements include spearheading the successful U.S. market entry of several critical-care injectables, which boosted Amphastar’s market share by 25%, and navigating complex EU regulatory approvals to establish manufacturing excellence in France. His visionary approach continues to position Amphastar as a leader in affordable, high-quality pharmaceuticals, blending operational efficiency with innovative growth initiatives.